Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 244

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part II, Item 15
Chunk 244
---
 further details.

43

In this selected financial information, we present adjusted revenues and pre-tax income from operations by our two operating segments, Pharmacy Benefit Services and Specialty and Care Services. 

Selected Financial InformationThree Months EndedSeptember 30,ChangeNine Months EndedSeptember 30,Change(Dollars and adjusted scripts in millions)2025202420252024Total adjusted revenuesPharmacy Benefit Services$34,091 $28,812 18 %$95,787 $81,549 17 %Specialty and Care Services26,300 23,825 10 76,110 66,862 14 Total adjusted revenues$60,391 $52,637 15 %$171,897 $148,411 16 %Pre-tax adjusted income from operationsPharmacy Benefit Services$975 $1,038 (6)%$2,352 $2,379 (1)%Specialty and Care Services928 838 11 2,681 2,476 8 Total pre-tax adjusted income from operations$1,903 $1,876 1 %$5,033 $4,855 4 %Pharmacy claim volume (1)558 531 5 %1,645 1,577 4 %

(1)Non-specialty network prescriptions filled through 90-day programs and home delivery prescriptions are counted as three claims. All other network and specialty prescriptions are counted as one claim.

Three and Nine Months Ended September 30, 2025 versus Three and Nine Months Ended September 30, 2024

Commentary in parentheses regarding percentage changes (or bps) represents the driver's impact on the overall category.

Adjusted revenues increased 15% and 16% for the three and nine months ended, respectively, primarily reflecting higher utilization of prescription drugs from customer growth in Pharmacy Benefit Services (+7% and +6%, respectively) and Specialty and Care Services (+5% and +6%, respectively) and an increase due to claims composition in Pharmacy Benefit Services (+3% and +4%, respectively). 

Pre-tax adjusted income from operations increased 1% and 4% for the three and nine months ended, respectively, primarily reflecting specialty pharmacy growth in Specialty and Care Services (+6% and +6%, respectively), and contract affordability improvements and customer growth in Pharmacy Benefit Services (+2% for the nine months ended), partially offset by strategic investments and initiatives to support business growth in Pharmacy and Benefit Services